Literature DB >> 10147245

Options for the management of obesity.

P L Beales1, P G Kopelman.   

Abstract

The need to treat obesity successfully can be measured by the medical penalty paid by the obese individual and the financial price paid by society in general. The management of obesity has 2 objectives: first, to produce significant weight reduction (10% of pretreatment bodyweight) and, second, to maintain this weight reduction. For the purpose of this paper, we have defined successful treatment as that maintaining significant weight loss for at least 5 years. A review of the literature confirms that there is no single outstanding treatment for obesity, and that clinicians must consider an individual's needs before selecting a particular method of weight reduction. The main determinants of suitability of any specific treatment are degree of obesity, concomitant medical disorders, urgency of treatment, and the individual's willingness to undergo the programme prescribed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 10147245     DOI: 10.2165/00019053-199400051-00005

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  61 in total

1.  Obesity in Europe: prevalence and consequences for use of medical care.

Authors:  J C Seidell; I Deerenberg
Journal:  Pharmacoeconomics       Date:  1994       Impact factor: 4.981

2.  Behavior modification in the treatment of obesity.

Authors:  S B Penick; R Filion; S Fox; A J Stunkard
Journal:  Psychosom Med       Date:  1971 Jan-Feb       Impact factor: 4.312

3.  Ileal bypass in the treatment of the hyperlipidemias.

Authors:  H Buchwald
Journal:  J Atheroscler Res       Date:  1969 Jul-Aug

4.  Sudden, unexpected death in avid dieters using the liquid-protein-modified-fast diet. Observations in 17 patients and the role of the prolonged QT interval.

Authors:  J M Isner; H E Sours; A L Paris; V J Ferrans; W C Roberts
Journal:  Circulation       Date:  1979-12       Impact factor: 29.690

5.  Pharmacological treatment of obesity.

Authors:  A C Sullivan; K Comai
Journal:  Int J Obes       Date:  1978

Review 6.  Progress in assessing the role of serotonin in the control of food intake.

Authors:  S Garattini; A Bizzi; S Caccia; T Mennini; R Samanin
Journal:  Clin Neuropharmacol       Date:  1988       Impact factor: 1.592

7.  Behavioral effects of vagotomy in humans.

Authors:  J G Kral
Journal:  J Auton Nerv Syst       Date:  1983-10

8.  The lipase inhibitor tetrahydrolipstatin binds covalently to the putative active site serine of pancreatic lipase.

Authors:  P Hadváry; W Sidler; W Meister; W Vetter; H Wolfer
Journal:  J Biol Chem       Date:  1991-02-05       Impact factor: 5.157

9.  Effect of exercise alone on the weight of obese women.

Authors:  G Gwinup
Journal:  Arch Intern Med       Date:  1975-05

10.  The Harrow Slimming Club: analysis of the results obtained in 249 members of a self-financing, non-profit-making group.

Authors:  R Seddon; J Penfound; J S Garrow
Journal:  J Hum Nutr       Date:  1981-04
View more
  5 in total

Review 1.  Effective management of obesity.

Authors:  S O'Meara; A M Glenny; C Wilson; A Melville; T A Sheldon
Journal:  Qual Health Care       Date:  1997-09

2.  Reasons for the epidemic of obesity in the US?

Authors: 
Journal:  Pharmacoeconomics       Date:  1994       Impact factor: 4.981

3.  The economics of treating obesity.

Authors:  J Hutton
Journal:  Pharmacoeconomics       Date:  1994       Impact factor: 4.981

Review 4.  Dexfenfluramine. An updated review of its therapeutic use in the management of obesity.

Authors:  R Davis; D Faulds
Journal:  Drugs       Date:  1996-11       Impact factor: 9.546

Review 5.  Orlistat.

Authors:  W McNeely; P Benfield
Journal:  Drugs       Date:  1998-08       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.